Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
87855904 | 8785590 | 4 | F | 201106 | 20160830 | 20120914 | 20160906 | PER | US-ALEXION-A201201700 | ALEXION | 31.23 | YR | F | Y | 0.00000 | 20160906 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
87855904 | 8785590 | 1 | PS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 1200 MG, SINGLE | T2-A67765C | 125166 | 1200 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | QD | |||||
87855904 | 8785590 | 2 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 900 MG, QW X 4 | 125166 | 900 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | /wk | ||||||
87855904 | 8785590 | 3 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 900 MG, Q2W | T2-A75446C | 125166 | 900 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | QOW | |||||
87855904 | 8785590 | 4 | SS | CELLCEPT | MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 | Unknown | UNK | Y | 0 | |||||||||
87855904 | 8785590 | 5 | C | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Unknown | 250 MG, QD | 41510.418 | MG | 0 | 250 | MG | QD | |||||
87855904 | 8785590 | 6 | C | TACROLIMUS. | TACROLIMUS | 1 | Unknown | UNK | 0 | ||||||||||
87855904 | 8785590 | 7 | C | PREDNISONE. | PREDNISONE | 1 | Unknown | UNK | 0 | ||||||||||
87855904 | 8785590 | 8 | C | METOPROLOL. | METOPROLOL | 1 | Unknown | UNK | 0 | ||||||||||
87855904 | 8785590 | 9 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | 0 | |||||||||||
87855904 | 8785590 | 10 | C | MYCOPHENOLATE | MYCOPHENOLIC ACID | 1 | Unknown | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
87855904 | 8785590 | 1 | Haemolytic uraemic syndrome |
87855904 | 8785590 | 4 | Product used for unknown indication |
87855904 | 8785590 | 5 | Prophylaxis |
87855904 | 8785590 | 6 | Product used for unknown indication |
87855904 | 8785590 | 7 | Product used for unknown indication |
87855904 | 8785590 | 8 | Product used for unknown indication |
87855904 | 8785590 | 9 | Product used for unknown indication |
87855904 | 8785590 | 10 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
87855904 | 8785590 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
87855904 | 8785590 | Blood lactate dehydrogenase increased | |
87855904 | 8785590 | Cytomegalovirus infection | |
87855904 | 8785590 | Haemoglobin decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
87855904 | 8785590 | 1 | 201206 | 201206 | 0 | |
87855904 | 8785590 | 2 | 201106 | 201107 | 0 | |
87855904 | 8785590 | 3 | 201107 | 0 | ||
87855904 | 8785590 | 4 | 201208 | 0 | ||
87855904 | 8785590 | 5 | 20110623 | 20120801 | 0 |